Skip to main content
ISTH 2023 Main banner
Back

    Ravindra Sarode, MD

    Chief of Pathology
    University of Texas Southwestern Medical Center
    Dallas, Texas, United States

    Ravi Sarode, MD, is a Tenured Professor of Pathology and Internal Medicine (Hematology/Oncology), the Chief of Pathology, and the Medical Director of Clinical Laboratory Services at the University of Texas Southwestern Medical Center in Dallas. He is the Medical Director of the Division of Transfusion Medicine and Hemostasis and holds the John H. Childers, MD, Professorship in Pathology. He is a Co-Editor-in-Chief of “Transfusion and Apheresis Science.” He is the past president of the American Society for Apheresis and one of the original writers of the ASFA guidelines. He was also invited to write anticoagulation reversal guidelines by the American Heart Association (2016-17) and the American College of Emergency Physicians (2018-2019), and the Society for Interventional Radiology (2017-18) on hemostasis and transfusion issues before any intervention. His research interests include TTP, HIT, RBCx, APS, anticoagulation monitoring and reversal, rebalanced hemostasis in cirrhosis, and restrictive transfusions. He has completed two randomized clinical trials (RCTs) on warfarin reversal comparing 4-factor PCC with plasma as an international coordinating principal investigator. He is currently one of the two coordinating international investigators for an RCT comparing low and high dose of 4F-PCC for treating major bleeds in patients on factor Xa inhibitors. His passion is to educate clinicians on the appropriate use of blood components and laboratory testing to avoid patient harm, use limited resources judiciously, and reduce healthcare costs. Currently, he serves as a board of directors for “The Foundation for Women and Girls with Blood Disorder” and is a co-chair of the anticoagulation committee of ISTH.

    Presentation(s):